These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28057386)

  • 1. Nanoparticles decorated with viral antigens are more immunogenic at low surface density.
    Brewer MG; DiPiazza A; Acklin J; Feng C; Sant AJ; Dewhurst S
    Vaccine; 2017 Feb; 35(5):774-781. PubMed ID: 28057386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin.
    Justewicz DM; Morin MJ; Robinson HL; Webster RG
    J Virol; 1995 Dec; 69(12):7712-7. PubMed ID: 7494280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
    Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
    J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation.
    Kelly HG; Tan HX; Juno JA; Esterbauer R; Ju Y; Jiang W; Wimmer VC; Duckworth BC; Groom JR; Caruso F; Kanekiyo M; Kent SJ; Wheatley AK
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32434990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
    Krashias G; Simon AK; Wegmann F; Kok WL; Ho LP; Stevens D; Skehel J; Heeney JL; Moghaddam AE; Sattentau QJ
    Vaccine; 2010 Mar; 28(13):2482-9. PubMed ID: 20132920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
    Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
    J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.
    Bale S; Goebrecht G; Stano A; Wilson R; Ota T; Tran K; Ingale J; Zwick MB; Wyatt RT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem.
    Tan HX; Jegaskanda S; Juno JA; Esterbauer R; Wong J; Kelly HG; Liu Y; Tilmanis D; Hurt AC; Yewdell JW; Kent SJ; Wheatley AK
    J Clin Invest; 2019 Feb; 129(2):850-862. PubMed ID: 30521496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
    Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
    Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost.
    Apostólico Jde S; Boscardin SB; Yamamoto MM; de Oliveira-Filho JN; Kalil J; Cunha-Neto E; Rosa DS
    PLoS One; 2016; 11(1):e0145637. PubMed ID: 26727218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recognition specificity of a murine helper T cell for hemagglutinin of influenza virus A/PR/8/34.
    Gerhard W; Hackett C; Melchers F
    J Immunol; 1983 May; 130(5):2379-85. PubMed ID: 6187854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.
    Johansson BE; Moran TM; Kilbourne ED
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6869-73. PubMed ID: 2958849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses.
    Yuan L; Chen WJ; Wang JY; Li Y; Tian D; Wang MX; Yu HT; Xu YC; Li D; Zhuang M; Ling H
    Virol Sin; 2018 Dec; 33(6):502-514. PubMed ID: 30569292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.
    Sealy R; Surman S; Hurwitz JL; Coleclough C
    Immunology; 2003 Apr; 108(4):431-9. PubMed ID: 12667204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.